Melasma severity and use duration among hormonal injection contraception users: a study in a puskesmas in Semarang

https://doi.org/10.22146/bkm.55033

Tjatur Sembodo(1*), Hesti Wahyuningsih Karyadini(2), Nurul Elvira Thamrin(3)

(1) Division of Public Health Sciences, Faculty of Medicine Sultan Agung Islamic University, Semarang
(2) Division of Public Health Sciences, Faculty of Medicine Sultan Agung Islamic University, Semarang
(3) Division of Public Health Sciences, Faculty of Medicine Sultan Agung Islamic University, Semarang
(*) Corresponding Author

Abstract


Purpose: This study examines the relationship between the duration of use of injected hormonal contraception and the severity of melasma.

Method: This cross-sectional study interviewed 60 users of one-month and three-month injection contraception through a consecutive sampling in Semarang's Bangetayu Community Health Center in January 2020. Melasma severity is based on face photo-taking and assessed with Melasma Area and Severity Index.

Results: Spearman's test showed no relationship betweenone-month injection contraceptionuse has no relationshipwith melasma severity (p = 0.357, p> 0.05). A similar finding was found in the three months of injection contraception users (p = 0.795, p> 0.05).

Conclusion: Use of injected contraception, whether one or three-month duration,  has nothing to do with melasma severity. Injectable contraceptives users should not worry about melasma.


Keywords


melasma; 1-month injection contraception; 3-month injection contraception

Full Text:

PDF


References

  1. Rekomendasi Praktik pilihan untuk penggunaan kontrasepsi. EGC;
  2. Selected Practice Recommendations for Contraceptive Use. Geneva: World Health Organization; 2017.
  3. Udiani AA. Hubungan Penggunaan Kontrasepsi Oral Dengan Kejadian Melasma Di Desa Ngebrak Kecamatan Gentan. s1, Universitas Muhammadiyah Surakarta. 2012.
  4. Jannah FW, Ariani D, Sariati Y. Hubungan Kejadian Melasma dengan Penggunaan Kontrasepsi Hormonal Suntik dan Pil Kombinasi di BPM Dwi Astutik, Desa Petungsewu, Dau, Kabupaten Malang. Journal of Issues in Midwifery. 2019;2: 17–29.
  5. Ministry of Health. Indonesia Health Profile 2018. Jakarta: Jakarta: Ministry of Health Republic of Indonesia; 2019.
  6. Affandi, B. and Albar, E. Contraception. Jakarta: PT Bina Pustaka Sarwono Prawirohardjo; 2011.
  7. Umborowati MA, Rahmadewi R. Studi Retrospektif: Diagnosis dan Terapi Pasien Melasma. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2014;26: 1–8.
  8. Setyawati, N. Kadek, Indira, IGAAE and Puspawati, NMD. Incident and Melasma Profile at Sanglah Central General Hospital Denpasar Period January 2014 to December 2014. E-Journal of Medika. 2019;8: 1–7.
  9. Cestari T, Peruzzo J, Giongo N. Definition, Incidence, and Etiology of Melasma in Brown Skin. In: E. H, Enriquez-Macarayo M, editors. Melasma and Vitiligo in Brown Skin. New Delhi: Springer; 2017. pp. 13–19.
  10. Soepardiman, I. Pigment Disorders. In: A. Menaldi, K. Bramono, and W Indriatmi, editor. Skin Disease and Gender. Jakarta: FK UI Publishing Agency; 2015. p. -.
  11. Dewi ADC. Gambaran efek samping kb suntik depo medroksi progesteron asetat pada akseptor. Jurnal ’Aisyiyah Medika. 2018;2. doi:10.36729/jam.v2i1.68
  12. Siagian A. Hubungan Antara Penggunaan Kontrasepsi Hormonal dengan Kejadian Melasma. 2017 [cited 19 Sep 2020]. Available: http://repositori.usu.ac.id/handle/123456789/20324
  13. Santoso, S. SPSS, Processing statistical data in a professional manner. Jakarta: PT Elex Media Komputindo; 2001.
  14. Sopiudin D. Gateway to understanding statistics, methodology, and epidemiology. Ciracas: Seto Corn; 2013.
  15. Tjay, TH and Rahardja, K. Important Drugs The Efficacy, Usage, and Side Effects. Jakarta: Elex Media Komputindo; 2013.
  16. Mahdalena I, Jusuf N, Putra I. Melasma characteristic in hormonal contraceptive acceptors at Kelurahan Mangga Kecamatan Medan Tuntungan, Medan-Indonesia. blog.balimedicaljournal.org. Available: https://blog.balimedicaljournal.org/index.php/bmj/article/view/1000
  17. Miranti A, Anwar AI, Djawad K, Patellongi I, Wahab S, Abdullah N. Analysis level of serum estradiol hormone of pregnant women with melasma. American Journal of Clinical and Experimental Medicine. 2016;4: 26–29.
  18. Wiedemann C, Nägele U, Schramm G, Berking C. Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro. Contraception. 2009;80: 292–298.
  19. Harini R. Differences in the Influence of the Use of Injecting Contraception (Cyclofem and Depoprogestin) on Increased Blood Pressure in Fertile Age Women in the Work Area of Pakisaji Public Health Center Malang. Journal of Nursing. 2010;1: 144–150.
  20. Damayanti DS, Pratiwi PI, Petricka G. The correlation among duration of oral contraception with the incidence of melasma in sumberwudi, lamongan, East Java, Indonesia. Proceedings of the International Conference on Applied Science and Health. 2017;0: 223–227.
  21. Novitasari I. Relationship of Fat Intake and Nutrition Status with Menstrual Cycles in NHigh School Students Columadu. Ririn Yuliati And Luluk, editor. Bachelor, Universitas Muhammadiyah Surakarta. 2016.
  22. Rizqiyana A. Hubungan Antara Kehamilan Trimester III Dengan Terjadinya Melasma Di RSUD Salatiga. s1, Universitas Muhammadiyah Surakarta. 2012.



DOI: https://doi.org/10.22146/bkm.55033

Article Metrics

Abstract views : 4850 | views : 1013

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Copyright (c) 2020 Berita Kedokteran Masyarakat

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Berita Kedokteran Masyarakat ISSN 0215-1936 (PRINT), ISSN: 2614-8412 (ONLINE).

Indexed by:

 

Web Analytics Visitor Counter